Delivery Order SPE2DE21D7020-SPE2D626F6885
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $7,074.77 by the Defense Health Agency's Medical Supply Chain for a Ranger Global DCB OTW 6.0 x 40mm 135cm medical device. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 19, 2025. This award represents a competitive procurement with no set-aside designation,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,349.06 by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 7.0 X 120MM 150CM medical devices. The contract, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, utilizes fixed-price pricing with economic price adjustment and was not set aside for any specific business type. The place of...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,133.48 by the Defense Health Agency's Medical Supply Chain on September 22, 2025, with an ultimate completion date of September 25, 2025. The contract, utilizing a fixed-price pricing structure with economic price adjustment provisions, covers the delivery of Ranger Global DCB OTW 5.0 x 200mm 150cm medical devices. Performance will take place at...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $44,802.45 by the Defense Health Agency's Medical Supply Chain on August 28, 2025. The contract, designated as RANGER GLOBAL DCB OTW 4.0 X 60MM 80CM, represents a specialized medical device procurement with an ultimate completion date of September 5, 2025. The award is not set aside for any specific business classification and will be...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 4.0 x 120MM 150CM medical devices, with a ceiling value of $30,554.50 under a fixed-price contract with economic price adjustment provisions. The award was made on August 4, 2025, with an ultimate completion date of August 11, 2025. This is an open competition contract with no set-aside designation, and the place of performance is Boston Scientific's facility...
- Boston Scientific Corp has been awarded a delivery order valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain for the procurement of Ranger Global DCB OTW 6.0 x 100mm 135cm medical devices. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of September 22, 2025. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace....
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $1,662.78 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract covers the delivery of a system assembly prototype measuring 190 centimeters with .014-inch diameter and 110-micrometer specifications, with a 3.2 French catheter component. This fixed-price delivery order with economic price adjustment provisions is set to be completed by August 11, 2025, and...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $2,157.35 by the Defense Health Agency's Medical Supply Chain on August 19, 2025. The contract covers a Selective MC Single Bern 130CM medical device and carries an ultimate completion date of August 26, 2025. This fixed-price delivery order with economic price adjustment represents one of numerous federal contract awards Boston Scientific...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F6885Delivery Order
Boston Scientific Corp, headquartered in Marlborough, Massachusetts, received a $8,317.78 fixed-price delivery order from the Defense Health Agency's Medical Supply Chain on October 29, 2025, for a Ranger Global DCB OTW 6.0 x 40mm 135cm medical device. The delivery order, which carries an ultimate completion date of November 5, 2025, was awarded without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, and represents a task order issued against the company's existing blanket purchase agreement with the Defense Health Agency. This delivery order aligns with Boston Scientific's established role as a critical supplier of specialized medical devices to federal healthcare agencies, including the Department of Veterans Affairs and Defense Health Agency. The company holds a $750 million blanket purchase agreement with the Defense Health Agency for radiation treatment devices, which was awarded on March 31, 2025, with a completion date of March 30, 2030. Boston Scientific's extensive portfolio of federal contracts encompasses advanced cardiovascular, interventional, diagnostic, and neuromodulation medical devices, positioning the company as a key provider of complex medical technologies across the defense and veterans healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 10/29/25 |